#news #biotech Alexion snaps up another biotech, paying $1.2B for Syntimmune

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Alexion snaps up another biotech, paying $1.2B for Syntimmune .Alexion’s rebuilding plan has continued with another bolt-on acquisition, this time a $400 million upfront deal for rare disease specialist Syntimmune.

from FierceBiotech: Biotech https://ift.tt/2ObZQqs